You searched for "blink"
RAPD in glaucoma screening
1 June 2014
| Lorraine North
|
EYE - Glaucoma
A study was conducted to investigate the relative afferent pupillary defect (RAPD) by swinging flashlight as a potentially useful screening test for glaucomatous optic neuropathy. The authors recruited 107 subjects with or without glaucoma from a clinic population. A medical...
Using frequency doubling technology perimetry to identify Alzheimer’s disease early
1 June 2014
| Claire Howard
|
EYE - Neuro-ophthalmology
Alzheimer’s disease is widely reported to be associated with deficits in visual function. Visual disturbances include impaired stereopsis, contrast sensitivity and motion detection. Deficits specific to the magnocellular pathway (MGC) have been identified in Alzheimer’s disease. This article compares the...
Antibiotic prophylaxis after intravitreal injections
1 June 2014
| Brian Ang
|
EYE - General
The use of topical antibiotics as prophylaxis after intravitreal injections is a contentious issue, especially now with increasing use of intravitreal anti-VEGF agents. In the Wills Eye Institute, prior to May 2011, all patients undergoing intravitreal injections in the office...
Sutureless 27-gauge needle intrascleral intraocular lens implantation
1 June 2014
| Brian Ang
|
EYE - General
The authors report on a prospective, non-comparative, interventional case series of patients undergoing sutureless intrascleral fixation of a posterior chamber three piece intraocular lens (IOL) using a 27-gauge needle for docking. Sutureless techniques have the advantage of not having complex...
PERG as a visual prognosticator in chiasmatic tumours
1 April 2014
| Anjali Gupta
|
EYE - General
Pattern electroretinogram (PERG) allows assessment of ganglion cell function and may therefore be used to assess anterior visual pathway dysfunction. This prospective non-randomised study assessed PERG before and after surgical removal of tumours in and around the sellar region compressing...
Macular slippage following macular hole surgery
1 April 2014
| Khadijah Basheer
|
EYE - General
The treatment of macular holes now involves peeling the internal limiting membrane (ILM) as well as vitrectomy and gas tamponade. It has been noted in previous studies that following an ILM peel the morphology of the macula is different. Tadayoni...
New mouse model of diabetes mellitus
1 April 2014
| Graham Wallace
|
EYE - Vitreo-Retinal
Diabetic retinopathy (DR) is a serious complication of diabetes. It is driven by the loss of pericytes, cells which control vascular function, due to excess formation of sugar alcohols by the enzyme aldose reductase (AR). AR has been shown to...
Macular thickness and visual fields
1 April 2014
| Lorraine North
|
EYE - Glaucoma
The authors describe a comparison of spectral domain OCT with Humphrey visual fields (HVF) mean deviation (MD) and pattern standard deviation (PSD), examining the retinal thickness of the macula and circumpapillary retinal nerve fibre layer (RNFL) defects. Seventy-three subjects who...
Prostaglandin levels in femto cataract surgery
Following previous reports of pupil size decrease after femtosecond treatment, the authors compare levels of prostaglandins in patients undergoing femtosecond assisted cataract surgery with those having routine cataract surgery. Patients with inflammatory eye disease, previous trauma surgery, age-related macular degeneration...Should intravitreal steroids be used in the initial treatment of post-op endophthalmitis?
1 October 2018
| Eulee Seow
|
EYE - Cataract, EYE - Refractive
|
adjuvant intravitreal dexamethasone, cataract surgery, postoperative bacterial endophthalmitis, randomized controlled trial
Endophthalmitis following cataract surgery is one of the most feared complications, and can have significant impact on the visual outcomes of patients. The role of steroids in the management of endopthalmitis is controversial. The aim of this paper was to...
Does Ozurdex affect perfusion status in vein occlusion?
1 October 2018
| Eulee Seow
|
EYE - Cataract, EYE - Refractive
|
intravitreal dexamethasone implant, peripheral nonperfusion, retinal vein occlusion, wide-field fluorescein angiography
Ozurdex (intravitreal dexamethasone implant) has been approved by National Institute of Health & Care Excellence (NICE) for treatment of patients with macular oedema associated with vein occlusion. This study looks at the change in peripheral perfusion status in patients with...